Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 10/20 | 0.56 |
| ▸ | ITGA4 | P13612 | 10/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7590998 | 0.89 | ITGB1 (0.62) | ITGB1ITGA4MEN1KMT2APOLB | |
| SCHEMBL7379255 | 0.89 | ITGA4 (0.45) | ITGB1ITGA4AHRRAB9AKMT2A | |
| SCHEMBL7379944 | 0.87 | ITGB1 (0.54) | ITGB1ITGA4HPGDALDH1A1MEN1 | |
| SCHEMBL7422070 | 0.87 | ITGB1 (0.59) | ITGB1ITGA4AHRMEN1KMT2A | |
| SCHEMBL7379263 | 0.86 | ITGA4 (0.55) | ITGB1ITGA4MEN1KMT2A | |
| SCHEMBL7426753 | 0.85 | ITGB1 (0.64) | ITGB1ITGA4MEN1KMT2APOLB | |
| SCHEMBL7422320 | 0.85 | ITGA4 (0.56) | ITGB1ITGA4MEN1KMT2A | |
| SCHEMBL7647170 | 0.83 | ITGA4 (0.62) | ITGB1ITGA4MEN1KMT2A | |
| SCHEMBL7417458 | 0.83 | ITGA4 (0.49) | ITGB1ITGA4HPGDALDH1A1AHR | |
| SCHEMBL7421722 | 0.83 | ITGB1 (0.61) | ITGB1ITGA4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6479519-B1 | INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE | AVENTIS PHARMA LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |
| EP-1027328-A1 | SUBSTITUTED ANILIDES | Aventis Pharma Limited (GB) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999023063-A1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LIMITED (GB) | 1999-05-14 | — | — | WO | disclosed |